Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Oct-24 8:36 PM View:  | Enliven Therapeutics, Inc. (ELVN) | 08-Oct-24 | Option Exercise | 10,420 | $14.10 | $146,925.00 | 47% 22.34K to 32.76K | |
| 10-Oct-24 8:36 PM View: | Enliven Therapeutics, Inc. (ELVN) | 08-Oct-24 | Planned Option Sale | 10,420 | $28.17 | $293,557.00 | (32%) 32.76K to 22.34K | |
| 17-Jun-24 5:22 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 13-Jun-24 | Option Exercise | 3,388 | -- | -- | 147% 2.3K to 5.69K | |
| 12-Apr-24 6:23 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Option Exercise | 53,400 | $13.21 | $705,266.00 | 239% 22.34K to 75.74K | |
| 12-Apr-24 6:23 PM View: | Enliven Therapeutics, Inc. (ELVN) | 11-Apr-24 | Planned Option Sale | 53,400 | $23.95 | $1,279,070.00 | (71%) 75.74K to 22.34K | |
| 12-Apr-24 6:23 PM View: | Enliven Therapeutics, Inc. (ELVN) | 10-Apr-24 | Option Exercise | 13,600 | $12.60 | $171,360.00 | 61% 22.34K to 35.94K | |
| 12-Apr-24 6:23 PM View: | Enliven Therapeutics, Inc. (ELVN) | 10-Apr-24 | Planned Option Sale | 13,600 | $21.01 | $285,744.00 | (38%) 35.94K to 22.34K | |
| 08-Apr-24 8:40 PM View: | Enliven Therapeutics, Inc. (ELVN) | 04-Apr-24 | Option Exercise | 3,485 | $12.60 | $43,911.00 | 16% 22.34K to 25.83K | |
| 08-Apr-24 8:40 PM View: | Enliven Therapeutics, Inc. (ELVN) | 04-Apr-24 | Planned Option Sale | 3,485 | $19.15 | $66,729.40 | (13%) 25.83K to 22.34K | |
| 03-Apr-24 9:32 PM View: | Enliven Therapeutics, Inc. (ELVN) | 01-Apr-24 | Option Exercise | 3,237 | $5.73 | $18,533.80 | 14% 22.34K to 25.58K | |
| 03-Apr-24 9:32 PM View: | Enliven Therapeutics, Inc. (ELVN) | 01-Apr-24 | Planned Option Sale | 3,237 | $19.08 | $61,758.40 | (13%) 25.58K to 22.34K | |
| 22-Mar-24 7:46 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Mar-24 | Option Exercise | 13,278 | $5.52 | $73,294.60 | 59% 22.34K to 35.62K | |
| 22-Mar-24 7:46 PM View: | Enliven Therapeutics, Inc. (ELVN) | 20-Mar-24 | Planned Option Sale | 13,278 | $19.16 | $254,462.00 | (37%) 35.62K to 22.34K | |
| 15-Aug-23 4:06 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 11-Aug-23 | Option Exercise | 2,302 | -- | -- | 100% 0 to 2.3K | |
| 22-Feb-23 8:25 PM View: | Enliven Therapeutics, Inc. (ELVN) | 22-Feb-23 | Private Sale | 32,861 | $4.66 | $153,132.00 | (27%) 120.7K to 87.83K | |
| 01-Feb-23 6:24 PM View: | Enliven Therapeutics, Inc. (ELVN) | 30-Jan-23 | Private Sale | 11,313 | $3.91 | $44,233.80 | (9%) 132.01K to 120.7K | |
| 01-Feb-22 5:02 PM View: | Enliven Therapeutics, Inc. (ELVN) | 28-Jan-22 | Grant | 131,400 | -- | -- | 2343% 5.61K to 137.01K | |
| 21-Dec-20 4:47 PM View: | Enliven Therapeutics, Inc. (ELVN) | 17-Dec-20 | Option Exercise | 4,999 | $3.15 | $15,746.90 | 100% 0 to 5.0K | |
| 21-Dec-20 4:47 PM View: | Enliven Therapeutics, Inc. (ELVN) | 17-Dec-20 | Planned Option Sale | 4,999 | $25.00 | $124,975.00 | (100%) 5.0K to 0 | |
| 16-Dec-20 4:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 14-Dec-20 | Option Exercise | 1 | $3.15 | $3.15 | 100% 0 to 1 | |
| 16-Dec-20 4:15 PM View: | Enliven Therapeutics, Inc. (ELVN) | 14-Dec-20 | Planned Option Sale | 1 | $25.00 | $25.00 | (100%) 1 to 0 |